Braden M Leonard - 12 Jun 2025 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
10%+ Owner
Signature
Braden Michael Leonard
Issuer symbol
ANTX
Transactions as of
12 Jun 2025
Net transactions value
-$218,000
Form type
4
Filing time
16 Jun 2025, 15:40:59 UTC
Previous filing
30 May 2025
Next filing
07 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leonard Braden Michael 10%+ Owner 65 E CEDAR - SUITE 2, ZIONSVILLE Braden Michael Leonard 16 Jun 2025 0001373603

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale $218,000 -200,000 -6.2% $1.09 3,017,432 28 May 2025 Holding of BML Investment Partners, L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Braden M Leonard is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.